Skip to content

Efficacy of nutrition therapy on treating esophageal cancer patients

Efficacy of medical nutrition therapy vs. general dietary advices on nutritional status of esophageal cancer patients receiving concurrent neo-adjuvant chemo-radiation

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016112931161N1
Enrollment
100
Registered
2017-06-25
Start date
2017-06-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophagus cancer. Malignant neoplasm of esophagus

Interventions

Intervention 1: Intervention: Medical nutrition therapy including dietary advises, oral nutrition support or enteral nutrition or parenteral nutrition according to patients' nutritional status and sig
Treatment - Other
Control group: General dietary advice
Intervention: Medical nutrition therapy including dietary advises, oral nutrition support or enteral nutrition or parenteral nutrition according to patients' nutritional status and signs and symptoms

Sponsors

Vice chancellor for research of Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients 18 years old and more referred to Reza Radiation Oncology Center which esophageal cancer is proven pathologically and agree to participate and fill the consent, will be enrolled. Patients who are end stage (who have metastasis, trachea, mediastinal main vessels or vertebra involvement), receive palliative care, history of other cancers, esophageal surgery, concurrent disabling diseases such as CHF, CRF, COPD, Liver failure, AIDS or active rheumatic diseases and also subjects who cannot fill the questionnaires will not be enrolled. patients who do not desire to continue cooperation in study will be excluded.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Nutritional Status. Timepoint: before radiotherapy, after radiotherapy, 4 to 6 weeks after radiotherapy. Method of measurement: PG-SGA tool (questionnaire).

Secondary

MeasureTime frame
Patient weight. Timepoint: Before radiotherapy, after radiotherapy, 4 to 6 weeks after radiotherapy. Method of measurement: weight scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSara Movahed

Mashhad University of Medical Sciences

movahheds921@mums.ac.ir+98 51 3880 2417

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026